DAPA-CKD: Significant Victory for CKD with or without Diabetes

被引：7

作者：

Patel, Ankit B. ^{[1
,2
]}

Mistry, Kavita ^{[2
,3
]}

Verma, Ashish ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, Renal Div, 75 Francis St, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA

来源：

TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2021年 / 32卷 / 06期

关键词：

CHRONIC KIDNEY-DISEASE; OUTCOMES;

D O I：

10.1016/j.tem.2021.02.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sodium glucose cotransporter 2 inhibitors (SGLT2i) have revolutionized the treatment of heart failure and diabetic kidney disease. The DAPA-CKD trial by Heerspink et al. evaluated primary kidney outcomes with dapagliflozin in both diabetic and non-diabetic patients and identified kidney protection by SGLT2i independent of diabetes mellitus.

引用

页码：335 / 337

页数：3

共 10 条

[1] Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial [J].

Cooper, Mark E. ;

Inzucchi, Silvio E. ;

Zinman, Bernard ;

Hantel, Stefan ;

von Eynatten, Maximilian ;

Wanner, Christoph ;

Koitka-Weber, Audrey .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 74 (05) :713-715

[2] Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease [J].

de Zeeuw, Dick ;

Akizawa, Tadao ;

Audhya, Paul ;

Bakris, George L. ;

Chin, Melanie ;

Christ-Schmidt, Heidi ;

Goldsberry, Angie ;

Houser, Mark ;

Krauth, Melissa ;

Heerspink, Hiddo J. Lambers ;

McMurray, John J. ;

Meyer, Colin J. ;

Parving, Hans-Henrik ;

Remuzzi, Giuseppe ;

Toto, Robert D. ;

Vaziri, Nosratola D. ;

Wanner, Christoph ;

Wittes, Janet ;

Wrolstad, Danielle ;

Chertow, Glenn M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (26) :2492-2503

[3] Dapagliflozin in Patients with Chronic Kidney Disease [J].

Heerspink, Hiddo J. L. ;

Stefansson, Bergur V. ;

Correa-Rotter, Ricardo ;

Chertow, Glenn M. ;

Greene, Tom ;

Hou, Fan-Fan ;

Mann, Johannes F. E. ;

McMurray, John J. V. ;

Lindberg, Magnus ;

Rossing, Peter ;

Sjostrom, C. David ;

Toto, Roberto D. ;

Langkilde, Anna-Maria ;

Wheeler, David C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1436-1446

[4] Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging [J].

Kidokoro, Kengo ;

Cherney, David Z. I. ;

Bozovic, Andrea ;

Nagasu, Hajime ;

Satoh, Minoru ;

Kanda, Eiichiro ;

Sasaki, Tamaki ;

Kashihara, Naoki .

CIRCULATION, 2019, 140 (04) :303-315

[5] A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010 [J].

Mills, Katherine T. ;

Xu, Yu ;

Zhang, Weidong ;

Bundy, Joshua D. ;

Chen, Chung-Shiuan ;

Kelly, Tanika N. ;

Chen, Jing ;

He, Jiang .

KIDNEY INTERNATIONAL, 2015, 88 (05) :950-957

[6]

Vallon V., 2020, ANN REV PHYSL, V83, P1

[7] The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial [J].

van Bommel, Erik J. M. ;

Muskiet, Marcel H. A. ;

van Baar, Michael J. B. ;

Tonneijck, Lennart ;

Smits, Mark M. ;

Emanuel, Anna L. ;

Bozovic, Andrea ;

Danser, A. H. Jan ;

Geurts, Frank ;

Hoorn, Ewout J. ;

Touw, Daan J. ;

Larsen, Emil L. ;

Poulsen, Henrik E. ;

Kramer, Mark H. H. ;

Nieuwdorp, Max ;

Joles, Jaap A. ;

van Raalte, Daniel H. .

KIDNEY INTERNATIONAL, 2020, 97 (01) :202-212

[8] CREDENCE: Significant Victory for Diabetic Kidney Disease [J].

Verma, Ashish ;

Patel, Ankit B. ;

Upadhyay, Ashish ;

Waikar, Sushrut S. .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (06) :391-393

[9] The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics [J].

Wheeler, David C. ;

Stefansson, Bergur, V ;

Batiushin, Mikhail ;

Bilchenko, Oleksandr ;

Cherney, David Z., I ;

Chertow, Glenn M. ;

Douthat, Walter ;

Dwyer, Jamie P. ;

Escudero, Elizabeth ;

Pecoits-Filho, Roberto ;

Furuland, Hans ;

Gorriz, Jose Luis ;

Greene, Tom ;

Haller, Hermann ;

Hou, Fan Fan ;

Kang, Shin-Wook ;

Isidto, Rey ;

Khullar, Dinesh ;

Mark, Patrick B. ;

McMurray, John J., V ;

Kashihara, Naoki ;

Nowicki, Michal ;

Persson, Frederik ;

Correa-Rotter, Ricardo ;

Rossing, Peter ;

Toto, Robert D. ;

Umanath, Kausik ;

Van Bui, Pham ;

Wittmann, Istvan ;

Lindberg, Magnus ;

Sjostrom, C. David ;

Langkilde, Anna Maria ;

Heerspink, Hiddo J. L. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (10) :1700-1711

[10] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Edwards, Jonathan L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) :1093-1093

← 1 →